Alfred Sandrock, President & CEO at Voyager Therapeutics, Inc. (VYGR), sold 33,288 shares at $4.45 ($148K) on 2025-02-11, disclosed to the SEC on 2025-02-12.
Open-market sale of $148k VYGR by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.45 | 16,644 | $74K | 50.0% |
| 2 | $4.45 | 16,644 | $74K | 50.0% |
| Total | $4.45 avg | 33,288 | $148K | 100% |
| Filing → |
| VYGR | SELL | 2026-02-20 | $40K | — | Filing → |
| VYGR | SELL | 2026-02-11 | $46K | — | Filing → |
| VYGR | SELL | 2025-04-04 | $37K | — | Filing → |